Abstract:Certain microRNAs (miRNAs/miRs) may be used as prognostic biomarkers in various types of cancer. The purpose of the present study was to identify miRNAs that were abnormally expressed in glioma of different grades, and to evaluate their clinical implications in patients with glioma. The differentially expressed miRNAs were evaluated from the expression profiles of six glioma tissues (three low-grade and three high-grade gliomas) determined using a microarray platform. Reverse transcription-quantitative polymerase chain reaction analysis was used to further verify the aberrant expression of the candidate miRNA in a set of 42 patients and 5 healthy controls. The miRNA target genes were predicted and the protein-protein interaction network was generated; furthermore, functional enrichment analysis of the target genes in Gene Ontology (GO) terms and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways was performed. Kaplan-Meier curves and Log-rank analysis, as well as multivariate Cox regression analysis were performed to assess the association of the candidate miRNA with patient survival. A total of 15 differentially expressed miRNAs, including 13 downregulated and 2 upregulated miRNAs, were identified by comparison of low-grade and high-grade glioma tissues. The miR-374a expression of high-grade gliomas was significantly lower than that of low-grade gliomas (fold change, -4.43; P=0.027). The expression levels of miR-374a gradually decreased with the increase of the pathological grade of glioma. Pearson's Chi-square test was used to determine the association of miR-374a expression with several clinicopathological factors. Furthermore, low expression of miR-374a was determined to be an independent prognostic marker and that it was significantly associated with overall survival (P=0.0213). GO and KEGG pathway analysis revealed that the target genes of miR-374a may be involved in the regulation of the RNA polymerase II promoter and mTOR signaling pathway. The four hub genes (CCND1, SP1, CDK4, CDK6) were also identified by PPI network analysis. In conclusion, the present study indicated that miR-374a may be used as a promising prognostic biomarker for the screening of high-risk populations and for the assessment of the prognosis of patients with glioma.

Low Expression of Microrna-320B Correlates with Tumorigenesis and Unfavorable Prognosis in Glioma.

Down-regulation of Mirna-320C Promotes Tumor Growth and Metastasis and Predicts Poor Prognosis in Human Glioma

Downregulation of MicroRNA-320d predicts poor overall survival and promotes the growth and invasive abilities in glioma.

MicroRNA-320 Inhibits Cell Proliferation in Glioma by Targeting E2F1

Correlation of Microrna-375 Downregulation with Unfavorable Clinical Outcome of Patients with Glioma

Downregulation of Microrna-374A Predicts Poor Prognosis in Human Glioma

RETRACTED: Downregulation of Mir-204 Expression Correlates with Poor Clinical Outcome of Glioma Patients

MicroRNA-509-3p Inhibits Cell Proliferation and Invasion Via Downregulation of X-linked Inhibitor of Apoptosis in Glioma.

MiR-320 Inhibits the Growth of Glioma Cells Through Downregulating PBX3

Decreased Expression of Mir-378 Correlates with Tumor Invasiveness and Poor Prognosis of Patients with Glioma.

Reduced Expression of Mir-3653 in Glioma and Its Correlations with Clinical Progression and Patient Survival

Correlation of microRNA-10b upregulation and poor prognosis in human gliomas

Downregulation of Mir-154 in Human Glioma and Its Clinicopathological and Prognostic Significance

MicroRNA 320, an Anti-Oncogene Target miRNA for Cancer Therapy

MiR-320b Aberrant Expression Enhances the Radioresistance of Human Glioma Via Upregulated Expression of ALDH1A3.

Upregulation of Mir-183 Expression and Its Clinical Significance in Human Brain Glioma

MicroRNA-520c Inhibits Glioma Cell Migration and Invasion by the Suppression of Transforming Growth Factor-Β Receptor Type 2

Mir-182 As a Prognostic Marker for Glioma Progression and Patient Survival

Decreased Expression of Microrna-107 Predicts Poorer Prognosis in Glioma

miR-181b Expression in Human Gliomas and Its Clinical Significance

Overexpression of Microrna-939-5p Contributes to Cell Proliferation and Associates Poor Prognosis in Glioma.